Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRKCB1 and Omega-3 in Major Depressive Disorder
NCT03899194Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Remission of acute phase at 12 weeks and Remission of consolidate and maintenance phase at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT03899194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899194.